Aquarius Surgical Technologies Inc.
AQQRF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $91 | $205 | $204 | $328 |
| % Growth | -55.6% | 0.7% | -37.8% | – |
| Cost of Goods Sold | $44 | $72 | $130 | $248 |
| Gross Profit | $47 | $133 | $74 | $79 |
| % Margin | 51.9% | 64.7% | 36.4% | 24.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $232 | $258 | $726 | $560 |
| SG&A Expenses | $564 | $592 | $726 | $767 |
| Sales & Mktg Exp. | $331 | $334 | $0 | $206 |
| Other Operating Expenses | $29 | $0 | $0 | $0 |
| Operating Expenses | $593 | $622 | $82 | $767 |
| Operating Income | -$546 | -$459 | -$644 | -$687 |
| % Margin | -598.2% | -223.5% | -316.1% | -209.8% |
| Other Income/Exp. Net | -$620 | -$290 | -$80 | -$223 |
| Pre-Tax Income | -$1,166 | -$749 | -$723 | -$859 |
| Tax Expense | $2 | $9 | $0 | $0 |
| Net Income | -$1,167 | -$758 | -$723 | -$859 |
| % Margin | -1,279.8% | -369.1% | -355.1% | -262.2% |
| EPS | -0.04 | -0.028 | -0.029 | -0.037 |
| % Growth | -45.5% | 5.5% | 21.8% | – |
| EPS Diluted | -0.04 | -0.028 | -0.029 | -0.037 |
| Weighted Avg Shares Out | 27,599 | 27,599 | 24,850 | 23,089 |
| Weighted Avg Shares Out Dil | 27,599 | 27,599 | 24,850 | 23,089 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $28 | $6 | $14 |
| Interest Expense | $304 | $288 | $219 | $213 |
| Depreciation & Amortization | $29 | $31 | $8 | $8 |
| EBITDA | -$833 | -$430 | -$517 | -$636 |
| % Margin | -913.1% | -209.4% | -253.9% | -194.2% |